Company: ACBM
Filing Date: 2025-07-23
Form Type: 10-Q
Source: 0001640334-25-001279
Chunk: 15

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-23
Form: 10-Q
Item: Item 1
Chunk 15
---
2023  -  $-   60,042,000  $60,042  $32,298,442  $(32,615,498) $(257,014)                             Imputed interest on related party loans  -   -   -   -   954   -   954 Net loss  -   -   -   -   -   (11,252)  (11,252)                             Balance, March 31, 2024  -   -   60,042,000   60,042   32,299,396   (32,626,750)  (267,312)                             Imputed interest on related party loans  -   -   -   -   1,057   -   1,057 Net loss  -   -   -   -       (10,143)  (10,143)                             Balance, June 30, 2024  -  $-   60,042,000  $60,042  $32,300,453  $(32,636,893) $(276,398)

For the Three and Six months ended June 30, 2023

          Additional  Deferred      Total   Preferred Stock  Common Stock   Paid in   Stock  Accumulated   Stockholders'    Shares    Amount    Shares    Amount    Capital   Compensation   Deficit   Equity                          Balance, December 31, 2022  -  $-   60,042,000  $60,042  $32,295,236  $(8,060,983) $(23,807,925) $486,370                                  Amortization of deferred stock compensation   -   -   -   -   -   3,928,100   -   3,928,100 Imputed interest on related party loans  -   -   -   -   788   -   -   788